Share Price and Basic Stock Data
Last Updated: January 28, 2026, 10:11 am
| PEG Ratio | 2.11 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Foseco India Ltd, operating in the Chemicals – Organic – Others sector, reported a significant revenue trajectory, with sales rising from ₹338 Cr in December 2021 to ₹477 Cr in December 2023. The latest trailing twelve months (TTM) sales stood at ₹593 Cr, indicating a robust growth pattern. Quarterly sales data reveals consistent improvement, with revenue increasing from ₹103 Cr in September 2022 to ₹123 Cr in September 2023, reflecting a year-on-year growth of approximately 19.4%. This growth momentum continued with projected sales reaching ₹141 Cr by September 2024, underscoring a positive trend in demand. The operating profit margin (OPM) averaged 18% over the past year, showcasing the company’s ability to maintain profitability amidst fluctuating costs. The company’s focus on operational efficiency and product innovation appears to contribute positively to its revenue performance, positioning it favorably within the competitive landscape.
Profitability and Efficiency Metrics
Foseco India Ltd’s profitability metrics demonstrate strong operational efficiency. The company recorded a net profit of ₹79 Cr for the TTM, reflecting a substantial increase from ₹73 Cr in December 2023. The net profit margin stood at 13.91% in December 2024, indicating a healthy profitability profile. The return on equity (ROE) was reported at 23.3%, considerably higher than the typical sector range, showcasing effective shareholder value creation. Efficiency ratios also support this positive outlook; with a cash conversion cycle (CCC) of -23 days, Foseco effectively manages its working capital. The interest coverage ratio (ICR) stood at an impressive 706.36x, indicating no reliance on debt to finance operations. This high ICR reflects the company’s robust earnings relative to its interest obligations, further enhancing its financial stability and operational flexibility.
Balance Sheet Strength and Financial Ratios
The balance sheet of Foseco India Ltd exhibits significant strength, characterized by low borrowings of just ₹2 Cr against total reserves of ₹363 Cr. This conservative financial structure allows the company to maintain flexibility in its operations and invest in growth initiatives without the burden of debt. The price-to-book value (P/BV) ratio stood at 7.48x, indicating a premium valuation relative to its book value, which is consistent with investor expectations for growth. The current ratio of 3.12x suggests a strong liquidity position, well above the typical sector threshold, ensuring the company can meet short-term obligations. Additionally, the return on capital employed (ROCE) was reported at 31.3%, reflecting effective utilization of capital to generate earnings. The financial ratios collectively depict a company that is not only profitable but also well capitalized and positioned for sustainable growth.
Shareholding Pattern and Investor Confidence
Foseco India Ltd maintains a stable shareholding pattern, with promoters holding 74.98% of the total shares, indicating strong control and confidence in the company’s direction. The public shareholding accounts for 24.22%, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) represent 0.12% and 0.68%, respectively. Notably, the increase in public shareholders from 11,157 in December 2022 to 13,602 by September 2025 reflects growing investor interest and confidence in the company’s prospects. The gradual rise in DII holdings, from 0.00% in December 2022 to 0.68% as of September 2025, suggests institutional endorsement of Foseco’s long-term strategy and performance. This stable and gradually expanding shareholder base may provide a buffer against market volatility and enhance the company’s credibility in the eyes of potential investors.
Outlook, Risks, and Final Insight
Looking ahead, Foseco India Ltd is positioned for continued growth, driven by its solid financial metrics and operational efficiency. However, potential risks include fluctuations in raw material costs and competitive pressures within the chemicals sector. The company’s reliance on a concentrated promoter stake may raise governance concerns among minority investors. Despite these risks, the strong financial fundamentals and consistent profitability provide a solid foundation for future expansion. Should the company successfully navigate these challenges and continue to innovate, it may further enhance its market position. Conversely, failure to adapt to changing market dynamics or operational inefficiencies could hinder growth. Overall, Foseco India Ltd’s current trajectory suggests a promising outlook, contingent on maintaining operational excellence and strategic agility in the face of industry challenges.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 58.9 Cr. | 165 | 437/135 | 137 | 392 | 0.06 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,020 Cr. | 8,855 | 14,250/8,150 | 50.8 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 27.0 Cr. | 90.0 | 329/84.1 | 13.4 | 26.9 | 1.11 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 205 Cr. | 257 | 435/163 | 11.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,410.67 Cr | 1,423.96 | 55.77 | 334.84 | 0.44% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 103 | 106 | 111 | 121 | 123 | 122 | 123 | 125 | 141 | 136 | 149 | 157 | 151 |
| Expenses | 88 | 88 | 95 | 103 | 107 | 103 | 103 | 101 | 117 | 114 | 121 | 130 | 123 |
| Operating Profit | 15 | 18 | 15 | 18 | 16 | 20 | 20 | 24 | 24 | 23 | 27 | 27 | 28 |
| OPM % | 15% | 17% | 14% | 15% | 13% | 16% | 16% | 19% | 17% | 17% | 18% | 17% | 18% |
| Other Income | 2 | 2 | 5 | 17 | 7 | 5 | 4 | 4 | 4 | 6 | 4 | 4 | -1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 2 | 2 | 3 |
| Profit before tax | 15 | 16 | 19 | 33 | 21 | 22 | 21 | 25 | 26 | 26 | 29 | 29 | 24 |
| Tax % | 26% | 25% | 26% | 17% | 29% | 25% | 25% | 26% | 26% | 26% | 26% | 26% | 31% |
| Net Profit | 11 | 12 | 14 | 28 | 15 | 16 | 16 | 18 | 19 | 20 | 22 | 22 | 16 |
| EPS in Rs | 17.11 | 19.20 | 22.30 | 43.31 | 23.13 | 25.54 | 24.82 | 28.97 | 29.95 | 30.61 | 33.93 | 33.71 | 25.82 |
Last Updated: January 12, 2026, 9:16 am
Below is a detailed analysis of the quarterly data for Foseco India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 151.00 Cr.. The value appears to be declining and may need further review. It has decreased from 157.00 Cr. (Jun 2025) to 151.00 Cr., marking a decrease of 6.00 Cr..
- For Expenses, as of Sep 2025, the value is 123.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 130.00 Cr. (Jun 2025) to 123.00 Cr., marking a decrease of 7.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Jun 2025) to 28.00 Cr., marking an increase of 1.00 Cr..
- For OPM %, as of Sep 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 17.00% (Jun 2025) to 18.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is -1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Jun 2025) to -1.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Jun 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Jun 2025) to 24.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Sep 2025, the value is 31.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Jun 2025) to 31.00%, marking an increase of 5.00%.
- For Net Profit, as of Sep 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Jun 2025) to 16.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 25.82. The value appears to be declining and may need further review. It has decreased from 33.71 (Jun 2025) to 25.82, marking a decrease of 7.89.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:22 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 227 | 263 | 292 | 340 | 358 | 362 | 323 | 251 | 338 | 407 | 477 | 525 | 593 |
| Expenses | 196 | 224 | 241 | 285 | 306 | 312 | 276 | 230 | 294 | 343 | 408 | 434 | 488 |
| Operating Profit | 31 | 39 | 51 | 55 | 51 | 51 | 46 | 21 | 44 | 63 | 70 | 91 | 105 |
| OPM % | 13% | 15% | 17% | 16% | 14% | 14% | 14% | 8% | 13% | 16% | 15% | 17% | 18% |
| Other Income | 2 | 3 | 2 | 2 | 3 | 4 | 8 | 6 | 6 | 7 | 33 | 18 | 14 |
| Interest | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 6 | 6 | 9 | 8 | 10 | 10 |
| Profit before tax | 27 | 38 | 48 | 51 | 48 | 50 | 50 | 21 | 43 | 61 | 95 | 98 | 108 |
| Tax % | 34% | 35% | 34% | 36% | 34% | 36% | 30% | 27% | 25% | 25% | 23% | 26% | |
| Net Profit | 18 | 25 | 32 | 33 | 32 | 32 | 35 | 15 | 33 | 46 | 73 | 73 | 79 |
| EPS in Rs | 27.90 | 38.50 | 49.68 | 51.80 | 49.43 | 50.17 | 54.07 | 24.18 | 51.15 | 71.98 | 114.27 | 114.35 | 124.07 |
| Dividend Payout % | 88% | 55% | 53% | 44% | 51% | 50% | 46% | 62% | 49% | 56% | 22% | 22% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | 16% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 31% |
| TTM: | 26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 39% |
| 3 Years: | 52% |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 20% |
| 3 Years: | 23% |
| Last Year: | 23% |
Last Updated: September 5, 2025, 4:15 am
Balance Sheet
Last Updated: December 4, 2025, 1:15 am
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 83 | 91 | 103 | 118 | 139 | 150 | 165 | 176 | 202 | 233 | 280 | 337 | 363 |
| Borrowings | 8 | 6 | 4 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Other Liabilities | 50 | 48 | 50 | 57 | 75 | 82 | 77 | 80 | 86 | 106 | 132 | 138 | 150 |
| Total Liabilities | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
| Fixed Assets | 28 | 26 | 26 | 26 | 23 | 20 | 34 | 31 | 35 | 31 | 39 | 45 | 44 |
| CWIP | 0 | 1 | 1 | 0 | 1 | 6 | 2 | 5 | 0 | 1 | 1 | 2 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 119 | 125 | 136 | 157 | 197 | 213 | 213 | 227 | 259 | 313 | 379 | 436 | 476 |
| Total Assets | 147 | 152 | 163 | 183 | 221 | 238 | 249 | 263 | 294 | 345 | 420 | 483 | 522 |
Below is a detailed analysis of the balance sheet data for Foseco India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Equity Capital, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 6.00 Cr..
- For Reserves, as of Jun 2025, the value is 363.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Dec 2024) to 363.00 Cr., marking an increase of 26.00 Cr..
- For Borrowings, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Dec 2024) which recorded 2.00 Cr..
- For Other Liabilities, as of Jun 2025, the value is 150.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 138.00 Cr. (Dec 2024) to 150.00 Cr., marking an increase of 12.00 Cr..
- For Total Liabilities, as of Jun 2025, the value is 522.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
- For Fixed Assets, as of Jun 2025, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Dec 2024) to 44.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Dec 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Other Assets, as of Jun 2025, the value is 476.00 Cr.. The value appears strong and on an upward trend. It has increased from 436.00 Cr. (Dec 2024) to 476.00 Cr., marking an increase of 40.00 Cr..
- For Total Assets, as of Jun 2025, the value is 522.00 Cr.. The value appears strong and on an upward trend. It has increased from 483.00 Cr. (Dec 2024) to 522.00 Cr., marking an increase of 39.00 Cr..
Notably, the Reserves (363.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 23.00 | 33.00 | 47.00 | 53.00 | 50.00 | 51.00 | 46.00 | 21.00 | 44.00 | 63.00 | 69.00 | 89.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103 | 101 | 113 | 107 | 103 | 88 | 82 | 94 | 80 | 76 | 78 | 84 |
| Inventory Days | 32 | 32 | 35 | 35 | 29 | 36 | 39 | 32 | 43 | 32 | 46 | 47 |
| Days Payable | 86 | 73 | 80 | 81 | 109 | 111 | 130 | 173 | 136 | 146 | 160 | 155 |
| Cash Conversion Cycle | 49 | 60 | 68 | 61 | 23 | 12 | -8 | -46 | -13 | -37 | -36 | -23 |
| Working Capital Days | 49 | 56 | 72 | 70 | 45 | 31 | 20 | 3 | 21 | 11 | 9 | 24 |
| ROCE % | 29% | 38% | 45% | 44% | 36% | 33% | 30% | 12% | 22% | 28% | 32% | 31% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| LIC MF Infrastructure Fund | 16,438 | 0.81 | 8.17 | 16,617 | 2026-01-26 03:55:35 | -1.08% |
| LIC MF Manufacturing Fund | 11,519 | 0.76 | 5.72 | N/A | N/A | N/A |
| LIC MF Focused Fund | 11,493 | 3.31 | 5.71 | 10,290 | 2026-01-26 03:55:35 | 11.69% |
| LIC MF Small Cap Fund | 4,051 | 0.33 | 2.01 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 114.35 | 114.28 | 71.98 | 51.16 | 24.17 |
| Diluted EPS (Rs.) | 114.35 | 114.28 | 71.98 | 51.16 | 24.17 |
| Cash EPS (Rs.) | 130.02 | 126.48 | 85.92 | 60.36 | 33.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 537.69 | 448.78 | 374.25 | 326.73 | 285.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 537.69 | 448.78 | 374.25 | 326.73 | 285.99 |
| Dividend / Share (Rs.) | 25.00 | 25.00 | 40.00 | 25.00 | 15.00 |
| Revenue From Operations / Share (Rs.) | 821.71 | 747.53 | 636.87 | 529.26 | 393.25 |
| PBDIT / Share (Rs.) | 169.88 | 142.70 | 109.97 | 77.04 | 42.28 |
| PBIT / Share (Rs.) | 154.21 | 130.50 | 96.03 | 67.83 | 33.02 |
| PBT / Share (Rs.) | 153.97 | 148.99 | 96.03 | 67.83 | 33.02 |
| Net Profit / Share (Rs.) | 114.35 | 114.28 | 71.98 | 51.16 | 24.17 |
| PBDIT Margin (%) | 20.67 | 19.08 | 17.26 | 14.55 | 10.75 |
| PBIT Margin (%) | 18.76 | 17.45 | 15.07 | 12.81 | 8.39 |
| PBT Margin (%) | 18.73 | 19.93 | 15.07 | 12.81 | 8.39 |
| Net Profit Margin (%) | 13.91 | 15.28 | 11.30 | 9.66 | 6.14 |
| Return on Networth / Equity (%) | 21.26 | 25.46 | 19.23 | 15.65 | 8.45 |
| Return on Capital Employeed (%) | 28.55 | 28.89 | 25.55 | 20.70 | 11.50 |
| Return On Assets (%) | 15.12 | 17.39 | 13.31 | 11.09 | 5.86 |
| Asset Turnover Ratio (%) | 1.16 | 1.25 | 1.27 | 1.21 | 0.98 |
| Current Ratio (X) | 3.12 | 2.84 | 2.91 | 2.98 | 2.74 |
| Quick Ratio (X) | 2.85 | 2.59 | 2.72 | 2.72 | 2.58 |
| Inventory Turnover Ratio (X) | 7.69 | 9.37 | 10.15 | 10.47 | 8.17 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 35.00 | 34.73 | 19.54 | 20.68 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 31.62 | 29.09 | 16.56 | 14.95 |
| Earning Retention Ratio (%) | 0.00 | 65.00 | 65.27 | 80.46 | 79.32 |
| Cash Earning Retention Ratio (%) | 0.00 | 68.38 | 70.91 | 83.44 | 85.05 |
| Interest Coverage Ratio (X) | 706.36 | 1246.69 | 0.00 | 0.00 | 38571.14 |
| Interest Coverage Ratio (Post Tax) (X) | 476.44 | 836.82 | 0.00 | 0.00 | 22053.57 |
| Enterprise Value (Cr.) | 2311.90 | 2210.85 | 1039.64 | 758.83 | 700.49 |
| EV / Net Operating Revenue (X) | 4.41 | 4.63 | 2.56 | 2.24 | 2.79 |
| EV / EBITDA (X) | 21.31 | 24.26 | 14.80 | 15.42 | 25.94 |
| MarketCap / Net Operating Revenue (X) | 4.90 | 5.11 | 3.02 | 2.69 | 3.33 |
| Retention Ratios (%) | 0.00 | 64.99 | 65.26 | 80.45 | 79.31 |
| Price / BV (X) | 7.48 | 8.52 | 5.14 | 4.35 | 4.59 |
| Price / Net Operating Revenue (X) | 4.90 | 5.11 | 3.02 | 2.69 | 3.33 |
| EarningsYield | 0.02 | 0.02 | 0.03 | 0.03 | 0.01 |
After reviewing the key financial ratios for Foseco India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Dec 24, the value is 114.35. This value is within the healthy range. It has increased from 114.28 (Dec 23) to 114.35, marking an increase of 0.07.
- For Diluted EPS (Rs.), as of Dec 24, the value is 114.35. This value is within the healthy range. It has increased from 114.28 (Dec 23) to 114.35, marking an increase of 0.07.
- For Cash EPS (Rs.), as of Dec 24, the value is 130.02. This value is within the healthy range. It has increased from 126.48 (Dec 23) to 130.02, marking an increase of 3.54.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 537.69. It has increased from 448.78 (Dec 23) to 537.69, marking an increase of 88.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 537.69. It has increased from 448.78 (Dec 23) to 537.69, marking an increase of 88.91.
- For Dividend / Share (Rs.), as of Dec 24, the value is 25.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Dec 23) which recorded 25.00.
- For Revenue From Operations / Share (Rs.), as of Dec 24, the value is 821.71. It has increased from 747.53 (Dec 23) to 821.71, marking an increase of 74.18.
- For PBDIT / Share (Rs.), as of Dec 24, the value is 169.88. This value is within the healthy range. It has increased from 142.70 (Dec 23) to 169.88, marking an increase of 27.18.
- For PBIT / Share (Rs.), as of Dec 24, the value is 154.21. This value is within the healthy range. It has increased from 130.50 (Dec 23) to 154.21, marking an increase of 23.71.
- For PBT / Share (Rs.), as of Dec 24, the value is 153.97. This value is within the healthy range. It has increased from 148.99 (Dec 23) to 153.97, marking an increase of 4.98.
- For Net Profit / Share (Rs.), as of Dec 24, the value is 114.35. This value is within the healthy range. It has increased from 114.28 (Dec 23) to 114.35, marking an increase of 0.07.
- For PBDIT Margin (%), as of Dec 24, the value is 20.67. This value is within the healthy range. It has increased from 19.08 (Dec 23) to 20.67, marking an increase of 1.59.
- For PBIT Margin (%), as of Dec 24, the value is 18.76. This value is within the healthy range. It has increased from 17.45 (Dec 23) to 18.76, marking an increase of 1.31.
- For PBT Margin (%), as of Dec 24, the value is 18.73. This value is within the healthy range. It has decreased from 19.93 (Dec 23) to 18.73, marking a decrease of 1.20.
- For Net Profit Margin (%), as of Dec 24, the value is 13.91. This value exceeds the healthy maximum of 10. It has decreased from 15.28 (Dec 23) to 13.91, marking a decrease of 1.37.
- For Return on Networth / Equity (%), as of Dec 24, the value is 21.26. This value is within the healthy range. It has decreased from 25.46 (Dec 23) to 21.26, marking a decrease of 4.20.
- For Return on Capital Employeed (%), as of Dec 24, the value is 28.55. This value is within the healthy range. It has decreased from 28.89 (Dec 23) to 28.55, marking a decrease of 0.34.
- For Return On Assets (%), as of Dec 24, the value is 15.12. This value is within the healthy range. It has decreased from 17.39 (Dec 23) to 15.12, marking a decrease of 2.27.
- For Asset Turnover Ratio (%), as of Dec 24, the value is 1.16. It has decreased from 1.25 (Dec 23) to 1.16, marking a decrease of 0.09.
- For Current Ratio (X), as of Dec 24, the value is 3.12. This value exceeds the healthy maximum of 3. It has increased from 2.84 (Dec 23) to 3.12, marking an increase of 0.28.
- For Quick Ratio (X), as of Dec 24, the value is 2.85. This value exceeds the healthy maximum of 2. It has increased from 2.59 (Dec 23) to 2.85, marking an increase of 0.26.
- For Inventory Turnover Ratio (X), as of Dec 24, the value is 7.69. This value is within the healthy range. It has decreased from 9.37 (Dec 23) to 7.69, marking a decrease of 1.68.
- For Dividend Payout Ratio (NP) (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 35.00 (Dec 23) to 0.00, marking a decrease of 35.00.
- For Dividend Payout Ratio (CP) (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 31.62 (Dec 23) to 0.00, marking a decrease of 31.62.
- For Earning Retention Ratio (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 65.00 (Dec 23) to 0.00, marking a decrease of 65.00.
- For Cash Earning Retention Ratio (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 68.38 (Dec 23) to 0.00, marking a decrease of 68.38.
- For Interest Coverage Ratio (X), as of Dec 24, the value is 706.36. This value is within the healthy range. It has decreased from 1,246.69 (Dec 23) to 706.36, marking a decrease of 540.33.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 24, the value is 476.44. This value is within the healthy range. It has decreased from 836.82 (Dec 23) to 476.44, marking a decrease of 360.38.
- For Enterprise Value (Cr.), as of Dec 24, the value is 2,311.90. It has increased from 2,210.85 (Dec 23) to 2,311.90, marking an increase of 101.05.
- For EV / Net Operating Revenue (X), as of Dec 24, the value is 4.41. This value exceeds the healthy maximum of 3. It has decreased from 4.63 (Dec 23) to 4.41, marking a decrease of 0.22.
- For EV / EBITDA (X), as of Dec 24, the value is 21.31. This value exceeds the healthy maximum of 15. It has decreased from 24.26 (Dec 23) to 21.31, marking a decrease of 2.95.
- For MarketCap / Net Operating Revenue (X), as of Dec 24, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.11 (Dec 23) to 4.90, marking a decrease of 0.21.
- For Retention Ratios (%), as of Dec 24, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 64.99 (Dec 23) to 0.00, marking a decrease of 64.99.
- For Price / BV (X), as of Dec 24, the value is 7.48. This value exceeds the healthy maximum of 3. It has decreased from 8.52 (Dec 23) to 7.48, marking a decrease of 1.04.
- For Price / Net Operating Revenue (X), as of Dec 24, the value is 4.90. This value exceeds the healthy maximum of 3. It has decreased from 5.11 (Dec 23) to 4.90, marking a decrease of 0.21.
- For EarningsYield, as of Dec 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Dec 23) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Foseco India Ltd:
- Net Profit Margin: 13.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.55% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.26% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 476.44
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.85
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 40.9 (Industry average Stock P/E: 55.77)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Gat Nos. 922 & 923, Pune District Maharashtra 412208 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ravi Moti Kirpalani | Chairperson & Director |
| Mr. Prasad Chavare | Managing Director & CEO |
| Mr. Mark Russel Collis | Director |
| Ms. Anita Belani | Director |
| Ms. Karena Cancilleri | Director |
| Mr. Amitabha Mukhopadhyay | Director |
FAQ
What is the intrinsic value of Foseco India Ltd?
Foseco India Ltd's intrinsic value (as of 28 January 2026) is ₹5299.53 which is 18.45% higher the current market price of ₹4,474.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,372 Cr. market cap, FY2025-2026 high/low of ₹6,846/3,205, reserves of ₹363 Cr, and liabilities of ₹522 Cr.
What is the Market Cap of Foseco India Ltd?
The Market Cap of Foseco India Ltd is 3,372 Cr..
What is the current Stock Price of Foseco India Ltd as on 28 January 2026?
The current stock price of Foseco India Ltd as on 28 January 2026 is ₹4,474.
What is the High / Low of Foseco India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Foseco India Ltd stocks is ₹6,846/3,205.
What is the Stock P/E of Foseco India Ltd?
The Stock P/E of Foseco India Ltd is 40.9.
What is the Book Value of Foseco India Ltd?
The Book Value of Foseco India Ltd is 579.
What is the Dividend Yield of Foseco India Ltd?
The Dividend Yield of Foseco India Ltd is 0.56 %.
What is the ROCE of Foseco India Ltd?
The ROCE of Foseco India Ltd is 31.3 %.
What is the ROE of Foseco India Ltd?
The ROE of Foseco India Ltd is 23.3 %.
What is the Face Value of Foseco India Ltd?
The Face Value of Foseco India Ltd is 10.0.
